Evidence map›Paper›PMID 40282905›Full record

ArticleMedicina (Kaunas, Lithuania)2025

A Real-World Analysis of the Population with Hepatitis C Virus Infection Affected by Type 2 Diabetes in Italy: Patients' Characteristics, Comorbidity Profiles and Treatment Patterns.

Edoardo Giovanni Giannini, Alessandra Mangia, Filomena Morisco, Pierluigi Toniutto, Angelo Avogaro, Stefano Fagiuoli, Claudio Borghi, Francesca Frigerio, Marta Nugnes, Chiara Veronesi and 13 more

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Edoardo Giovanni GianniniGastroenterology Unit, Department of Internal Medicine, University of Genoa, 16126 Genoa, Italy.ORCID 0000-0001-8526-837X
Alessandra MangiaLiver Unit, Department of Medical Sciences, Fondazione "Casa Sollievo della Sofferenza" IRCCS, 71013 San Giovanni Rotondo, Italy.ORCID 0000-0002-2600-3555
Filomena MoriscoGastroenterology Unit, Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80138 Naples, Italy.
Pierluigi ToniuttoHepatology and Liver Transplantation Unit, University of Udine, 33100 Udine, Italy.ORCID 0000-0002-2566-3041
Angelo AvogaroDepartment of Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, 35128 Padua, Italy.
Stefano FagiuoliGastroenterology Hepatology and Transplantation Unit, ASST Papa Giovanni XXIII, 24127 Bergamo, Italy.ORCID 0000-0001-8308-0701
Claudio BorghiDepartment of Medical and Surgical Sciences, IRCCS AOU S. Orsola di Bologna, 40138 Bologna, Italy.ORCID 0000-0001-8039-8781
Francesca FrigerioGilead Sciences, 20124 Milan, Italy.ORCID 0009-0004-6498-4712
Marta NugnesCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.
Chiara VeronesiCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0003-2852-2022
Maria CappuccilliCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0002-2592-9532
Margherita AndrettaUOC Assistenza Farmaceutica Territoriale, Azienda ULSS 8 Berica, 36100 Vicenza, Italy.
Marcello BaccaProgrammazione e Controllo di Gestione, ASL Brindisi, 72100 Brindisi, Italy.
Antonella BarbieriSC Farmaceutica Territoriale, Azienda Sanitaria Locale di Vercelli (ASL VC), 13100 Vercelli, Italy.
Fausto BartoliniDipartimento Farmaceutico USL Umbria 2, Coordinatore della Cabina di Regia Regione Umbria Sulla Governance Farmaceutica, 05100 Terni, Italy.
Gianmarco ChinellatoUOC Assistenza Farmaceutica Territoriale, Azienda ULSS 8 Berica, 36100 Vicenza, Italy.
Andrea CiacciaServizio Farmaceutico Territoriale, ASL Foggia, 71100 Foggia, Italy.
Renato LombardiServizio Farmaceutico Territoriale, ASL Foggia, 71100 Foggia, Italy.ORCID 0009-0005-7759-2141
Daniela ManciniUOSD Pianificazione Acquisti Farmaci e Beni Sanitari, ASL Brindisi, 72100 Brindisi, Italy.
Romina PagliaroUOC Farmaceutica Territoriale, Azienda Sanitaria Locale Roma 5, 00019 Tivoli, Italy.
Loredana UbertazzoUOC Farmacia Territoriale, ASL Roma 4, 00053 Civitavecchia, Italy.
Luca Degli EspostiCliCon S.r.l. Società Benefit, Health, Economics & Outcomes Research, 40137 Bologna, Italy.ORCID 0000-0002-7020-6659
Francesca Romana PonzianiLiver Unit, CEMAD-Centro Malattie dell'Apparato Digerente, Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0000-0002-5924-6238

Funding

Gilead Sciences (Italy) not applicable
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 2Hepatitis CAdultAgedAntiviral AgentsCohort StudiesComorbidityFemaleHumansItalyMaleMiddle AgedRisk FactorsAntiviral Agentsantiviral therapiesdirect-acting antiviralshepatitis C viruspangenotypic direct-acting antiviralsreal-world evidencetype 2 diabetes

Identifiers

PMID40282905
PMCPMC12028345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.